Severe Thrombocytopenia Two Weeks Following Immunization with the Janssen Ad26.CoV2.S Vaccine
Immune thrombocytopenia (ITP) has been associated with immunizations with various proposed mechanisms, including overactivation of the immune system and production of antibodies against circulating platelets. ITP has also been associated with several viral infections, including HCV, HIV, and most re...
Saved in:
Main Authors: | Bana Antonios, Markie Zimmer, Emma Herrman, Ramona Berghea |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/7208401 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial
by: Jelena Tica, et al.
Published: (2025-12-01) -
Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-06-01) -
Rapid Onset Severe Immune Thrombocytopenia following mRNA COVID-19 Vaccine in a Young Patient
by: Jorge Avila, et al.
Published: (2023-01-01) -
Pentavalent Vaccine‐Induced Immune Thrombocytopenia: A Case Report From Nepal
by: Ramesh Khadayat, et al.
Published: (2025-01-01) -
Research on the Safety Thickness of Tunnel Outburst Prevention in Water-Rich Fault Fracture Zone Based on Janssen’s Theory
by: Zuliang Zhong, et al.
Published: (2022-01-01)